Search Results for: CDKN2A

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
E2F1 E2F transcription factor 1
  • Activation of NOXA and translocation to mitochondria
  • Inhibition of replication initiation of damaged DNA by RB1/E2F1
  • Transcription of E2F targets under negative control by DREAM complex
  • Transcription of E2F targets under negative control by DREAM complex
  • Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
  • Activation of PUMA and translocation to mitochondria
  • Pre-NOTCH Transcription and Translation
  • Pre-NOTCH Transcription and Translation
  • Oxidative Stress Induced Senescence
  • Oncogene Induced Senescence
  • TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
  • G2 Phase
  • Cyclin E associated events during G1/S transition
  • G1/S-Specific Transcription
  • G1/S-Specific Transcription
  • Cyclin D associated events in G1
  • Cyclin A:Cdk2-associated events at S phase entry
  • Transcriptional Regulation by E2F6
  • Transcriptional regulation of granulopoiesis
  • Transcriptional regulation of granulopoiesis
  • Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)
E4F1 E4F transcription factor 1
EEF2 eukaryotic translation elongation factor 2
  • Peptide chain elongation
  • Peptide chain elongation
  • Uptake and function of diphtheria toxin
  • Synthesis of diphthamide-EEF2
  • Synthesis of diphthamide-EEF2
  • Neutrophil degranulation
  • Protein methylation
  • Adenosine-5-Diphosphoribose
  • Diphthamide
  • Guanosine-5'-Diphosphate
  • N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE
  • Esketamine
  • Moxetumomab pasudotox
EFHC2 EF-hand domain containing 2
EGR1 early growth response 1
  • Regulation of PTEN gene transcription
  • Regulation of PTEN gene transcription
  • NGF-stimulated transcription
  • NGF-stimulated transcription
  • Interferon alpha/beta signaling
EPHA2 EPH receptor A2
  • EPH-Ephrin signaling
  • EPH-Ephrin signaling
  • EPHA-mediated growth cone collapse
  • EPHA-mediated growth cone collapse
  • EPH-ephrin mediated repulsion of cells
  • EPH-ephrin mediated repulsion of cells
  • RAC1 GTPase cycle
  • RAC2 GTPase cycle
  • RHOG GTPase cycle
  • RHOU GTPase cycle
  • RAC3 GTPase cycle
  • RHOV GTPase cycle
  • RND3 GTPase cycle
  • RND2 GTPase cycle
  • RND1 GTPase cycle
  • Dasatinib
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • Regorafenib
  • Fostamatinib
EPHA3 EPH receptor A3
  • EPH-Ephrin signaling
  • EPH-Ephrin signaling
  • EPHA-mediated growth cone collapse
  • EPHA-mediated growth cone collapse
  • EPH-ephrin mediated repulsion of cells
  • EPH-ephrin mediated repulsion of cells
  • Fostamatinib
EXOC2 exocyst complex component 2
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Insulin processing
  • VxPx cargo-targeting to cilium
FGFR4 fibroblast growth factor receptor 4
  • PI3K Cascade
  • PIP3 activates AKT signaling
  • betaKlotho-mediated ligand binding
  • FGFR4 mutant receptor activation
  • FGFR4 ligand binding and activation
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • Phospholipase C-mediated cascade; FGFR4
  • FRS-mediated FGFR4 signaling
  • SHC-mediated cascade:FGFR4
  • PI-3K cascade:FGFR4
  • Negative regulation of FGFR4 signaling
  • Signaling by FGFR4 in disease
  • RAF/MAP kinase cascade
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • Heparin
  • Ponatinib
  • Lenvatinib
  • Infigratinib
  • Erdafitinib
  • Pemigatinib
  • Futibatinib
FN1 fibronectin 1
  • Platelet degranulation
  • Degradation of the extracellular matrix
  • Degradation of the extracellular matrix
  • Fibronectin matrix formation
  • Cell surface interactions at the vascular wall
  • Molecules associated with elastic fibres
  • Integrin cell surface interactions
  • Syndecan interactions
  • Non-integrin membrane-ECM interactions
  • ECM proteoglycans
  • Integrin signaling
  • GRB2:SOS provides linkage to MAPK signaling for Integrins
  • p130Cas linkage to MAPK signaling for integrins
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • MAP2K and MAPK activation
  • Interleukin-4 and Interleukin-13 signaling
  • Signaling by moderate kinase activity BRAF mutants
  • Signaling by high-kinase activity BRAF mutants
  • Signaling by BRAF and RAF1 fusions
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • MET activates PTK2 signaling
  • Post-translational protein phosphorylation
  • GPER1 signaling
  • Attachment of bacteria to epithelial cells
  • Signaling downstream of RAS mutants
  • Signaling by RAF1 mutants
  • ALK mutants bind TKIs
  • Signaling by ALK fusions and activated point mutants
  • Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
  • Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
  • Developmental Lineage of Pancreatic Ductal Cells
  • Zinc
  • Lanoteplase
  • Ocriplasmin
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
FRAT2 FRAT regulator of Wnt signaling pathway 2
  • Beta-catenin phosphorylation cascade
  • Disassembly of the destruction complex and recruitment of AXIN to the membrane
GALNT12 polypeptide N-acetylgalactosaminyltransferase 12
  • Defective GALNT12 causes CRCS1
  • O-linked glycosylation of mucins
GAPDH glyceraldehyde-3-phosphate dehydrogenase
  • Glycolysis
  • Gluconeogenesis
  • NADH
  • Adenosine-5-Diphosphoribose
  • Thionicotinamide-Adenine-Dinucleotide
  • 4-(2-Aminoethyl)Benzenesulfonyl Fluoride
  • Xanthinol
  • Copper
  • Artenimol
GGA1 golgi associated, gamma adaptin ear containing, ARF binding protein 1
  • TBC/RABGAPs
  • Amyloid fiber formation
GGA3 golgi associated, gamma adaptin ear containing, ARF binding protein 3
  • TBC/RABGAPs
  • MET receptor recycling
  • Amyloid fiber formation
GLIPR2 GLI pathogenesis related 2
  • L-cysteic acid
GLIS1 GLIS family zinc finger 1
GLIS2 GLIS family zinc finger 2
  • Nephronophthisis-medullary cystic kidney disease, including; Nephronophthisis (NPH) ; Nephronophthisis-like nephropathy 1; Medullary cystic kidney disease 1; Medullary cystic kidney disease 2 (MSKD2)
GMNN geminin DNA replication inhibitor
  • Assembly of the pre-replicative complex
  • Activation of the pre-replicative complex
  • Switching of origins to a post-replicative state
GSPT1 G1 to S phase transition 1
  • Eukaryotic Translation Termination
  • Eukaryotic Translation Termination
  • Regulation of expression of SLITs and ROBOs
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Guanosine-5'-Diphosphate

Page 12 out of 18 pages